Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
Feature
4768764591_9e4f7f0eb8_z

Phamaceutical trade lobby responds to Brexit deal

November 15, 2018 Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics

The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …
News

Pfizer defeated in Britain’s highest court over Lyrica patent

November 15, 2018 Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma

American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …
News

Company tackling antimicrobial resistance appoint former Bayer VP as new managing director

November 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …
Appointment
diabetes-777001_960_720

3 in 4 UK diabetes patients suffer from mental health issues, says report

November 14, 2018 Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma

To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …
News
michael_boyd

Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs

November 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
Appointment

Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma

November 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
Feature
dave_tudor

GSK veteran Dave Tudor joins MMIC in Scotland

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing

GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
Appointment
eisa0001

Eisai’s Lenvima wins over NICE in liver cancer in just three months

November 9, 2018 Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma

Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines

The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
News
nice_new_london_office_internal_2_8

NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis

November 9, 2018 Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma

Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …
News

NHS diabetes prescriptions top £1 billion a year

November 9, 2018 Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma

The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …
News
opioid_pills

Alabama’s biggest insurer will no longer cover OxyContin prescriptions

November 9, 2018 Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids

The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …
News
helena-baker

Living with fibular hemimelia

November 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cambridge rare disease network, diagnosis, fibular hemimelia, rare disease, therapy

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease …
Feature
bicycle_therapeutics

Bicycle Therapeutics picks up former Pfizer head as new SVP of Pre-Clinical Development

November 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Cambridge based biotechnology firm Bicycle therapeutics, has announced former Pfizer head Dr Phil Jeffrey as the company’s new Senior …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026